Semaglutide injection improves body mass index (BMI) and overall body weight by regulating blood sugar and encouraging weight reduction
Further outcomes were thirst perception during the preceding weeks and during the evaluation visit, 24-hour urinary output, day- and nighttime voiding frequency, quality of life, serum and urine electrolytes and osmolality, and adverse effects, e.g., gastrointestinal symptoms
Thirty-day outcomes of sleeve gastrectomy versus Roux-en-Y gastric bypass: first report based on Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database
Its still a research peptide, and studies are ongoing to confirm its efficacy and safety profile
Keep the product out of reach of children
Semaglutide has been associated with a reduced risk of major cardiovascular events